title: Caspofungin versus liposomal amphotericin B for empirical therapy.
authors.forename: Francisco M
authors.initials: FM
authors.lastname: Marty
authors.forename: Colleen M
authors.initials: CM
authors.lastname: Lowry
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D000077336:Caspofungin; D054714:Echinocandins; D005334:Fever / Q000209:etiology; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D009503:Neutropenia / Q000209:etiology; D010456:Peptides, Cyclic / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage; D015996:Survival Rate; D014230:Triazoles / Q000008:administration & dosage; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole